These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33253686)

  • 21. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.
    Annavajhala MK; Gomez-Simmonds A; Macesic N; Sullivan SB; Kress A; Khan SD; Giddins MJ; Stump S; Kim GI; Narain R; Verna EC; Uhlemann AC
    Nat Commun; 2019 Oct; 10(1):4715. PubMed ID: 31624266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CHANGES IN MICROBIOCENOSIS OF THE COLON IN PATIENTS WITH CHRONIC LIVER DISEASE AND LATENT HEPATIC ENCEPHALOPATHY].
    Teterina LA; Curcumia DB; Seliverstov PV; Radchenko VG
    Eksp Klin Gastroenterol; 2015; (11):38-44. PubMed ID: 27214986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
    Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
    Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.
    Xu R; Tan C; Zhu J; Zeng X; Gao X; Wu Q; Chen Q; Wang H; Zhou H; He Y; Pan S; Yin J
    Crit Care; 2019 May; 23(1):195. PubMed ID: 31151471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the gut-liver axis in liver disease.
    Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
    J Hepatol; 2017 Nov; 67(5):1084-1103. PubMed ID: 28526488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbiosis and liver diseases (Review).
    Nishikawa H; Fukunishi S; Asai A; Yokohama K; Ohama H; Nishiguchi S; Higuchi K
    Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34328191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysbiosis in gastrointestinal disorders.
    Chang C; Lin H
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):3-15. PubMed ID: 27048892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in Relationships with Causes and Prevention of Liver Diseases (Review).
    Nguepi TIS; Song H
    Int J Med Mushrooms; 2020; 22(6):509-519. PubMed ID: 32865893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota.
    Vasco M; Paolillo R; Schiano C; Sommese L; Cuomo O; Napoli C
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):290-300. PubMed ID: 30173786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gut microbiome in end-stage lung disease and lung transplantation.
    Zhang S; Swarte JC; Gacesa R; Knobbe TJ; Kremer D; Jansen BH; de Borst MH; ; Harmsen HJM; Erasmus ME; Verschuuren EAM; Bakker SJL; Gan CT; Weersma RK; Björk JR
    mSystems; 2024 Jun; 9(6):e0131223. PubMed ID: 38712927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases.
    Singh B; Qin N; Reid G
    Inflamm Allergy Drug Targets; 2015; 14(2):84-93. PubMed ID: 26817477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.